Emergent BioSolutions received a $64.5 million contract modification to supply a botulism treatment to the Health and Human Services Department. The modification was made to an existing 10-year ...
Emergent Biosolutions (NYSE:EBS) on Tuesday held its 2026 Annual Meeting of Stockholders, where shareholders voted on director elections, auditor ratification, executive compensation, and an amendment ...
BALTIMORE (WJZ)--During the darkest days of the pandemic, Emergent BioSolutions' Baltimore facility emerged as a bright spot. Congressional investigation finds Emergent BioSolutions—once hailed as a ...
Last month, the FDA showed it may be ready to play ball on approving nonprescription naloxone. Now, one of the overdose reversal drug’s flagship brands—Emergent BioSolutions’ nasal spray Narcan—is ...
SPRINGFIELD, OR / ACCESS Newswire / October 28, 2025 / Emergent has announced the official deployment of its NERIS-compliant Record Management System (RMS) update, enabling public safety departments ...
A failed government-arranged marriage between ill-suited partners has devolved into one last contract squabble. Monday, Emergent BioSolutions, which made high-profile errors in the production of two ...
SO, YEP YOU GOD I DO AFTER TAKING AN OATH EMERGENT BIOSOLUTIONS CEO OWNED THE PRODUCTION PROBLEMS. IN CORONAVIRUS VACCINE BACK IN MARCH AS CEO, I TAKE FULL RESPONSIBILITY FOR THAT EXECUTIVES FROM THE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results